DR. M-A VAN BOGAERT

Active

Private limited companyfounded 2021active for 5 yearsSterrenborgstraat 11, 2140 Antwerpen, BelgiumKBO/BCE: BE 0770.364.892

Summary

DR. M-A VAN BOGAERT has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €62,075 and a net result of €57,075. Equity is growing by about 4.6% per year across the filed financial years. Its solvency ranks better than 37% of 20,612 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow Report Compare

DR. M-A VAN BOGAERTActiveChecked score 95/100

Risk analysis Report Compare

Activity

General medical practice

NACE 86210

1 site

Size

€130,966total assets 2025

Equity: €62,075
Profit: €57,075

Turnover not published (micro format)

Financial health

95 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: < 0.1%

Structure

2025 accounts 49 days early1 of 2 deeds summarised

Why 95lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.85, cash €100,917Size: total assets €130,966Figures for financial year 2025 (filed 12-06-2026)Show the evidence

Checked score

Score 2025

95 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 63% of its sector peers (NACE 86, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Strong

Solvency 72-1

equity 47.4% of total assets

Liquidity 73-2

short-term debt 52.6% · cash 77.1%

Profitability 100=

return on assets 43.6%

Bankruptcy probability, 12 months

< 0.1% Very low

0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,124 companies, NACE 86, micro)

Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026lowest value 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026highest value 10-2026: < 0.1%● unchanged vs 09-2026

Credit of up to €5,000 on 30-day terms is acceptable

Liquidity ample (current ratio 1.85, compared with 1.81 in 2024, above the usual 1.5; short-term debt: 52.6% and cash: 77.1% of total assets), but 52.6% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 38% on solvency, 55% on liquidity, 80% on profitability and 78% on growth.

The bankruptcy probability was computed on 26-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskneutral

Sector: Human health activities (NACE 86)

KBO

Liquidity: current ratio 1.85, cash €100,917

NBB · annual accounts

Size: total assets €130,966

Companies of this size fail less often; how much that weighs depends on the rest of its profile.

NBB · annual accounts

Figures for financial year 2025 (filed 12-06-2026)

NBB · annual accounts

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 12-06-2026, 49 days ahead of the deadline.

NBB · 5 filings

Deviation from the deadline

2025

49 days early

2024

49 days early

2023

47 days early

2022

47 days early

2021

33 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 5 accounts on average 45 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 14 June (5 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

27-10-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

12-06-2026 Annual accounts filedfinancial year 2025 · micro…
31-12-2025 Highest result from 2021 to 2025net €57,075 ▲50.4%
12-06-2025 Annual accounts filedfinancial year 2024 · micro…

Key points

Positive: Always filed on timeaccounts within the deadline every year 5 years View
Positive: 5 profitable years in a rowprofit 2025: €57,075 5 years View
Total assets 20255 financial years filed €130,966 View

By topic

Financials

Financial year: 2025
Total assets: €130,966
Profit: €57,075
Solvency: 47.4%

Total assets▲ 45.3%

Net result

20212025

Go to Financials

Timeline

Events: 8
Since: 2022
Next accounts: by 31-07-2027

14-06-2024Annual accounts filed
23-11-2023Registered office
14-06-2023Annual accounts filed

Go to Timeline

Company details

Sites: 1

Legal form: Private limited company
Activity: General medical practiceNACE 86210
Founded: 25-06-2021
Year ends: 31-12
Peppol: Reachable for e-invoices

Go to Company details

Key facts about DR. M-A VAN BOGAERT

What is the company number of DR. M-A VAN BOGAERT?: 0770.364.892. In Belgium the VAT number is the company number with BE in front: BE 0770.364.892.
Where is DR. M-A VAN BOGAERT based?: The registered office is at Sterrenborgstraat 11, 2140 Antwerpen.Company details
What does DR. M-A VAN BOGAERT do?: According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR. M-A VAN BOGAERT?: Private limited company (BV).
When was DR. M-A VAN BOGAERT founded?: On 25-06-2021.
Is DR. M-A VAN BOGAERT still active?: Yes, DR. M-A VAN BOGAERT is an active enterprise in the KBO register.
What is the turnover of DR. M-A VAN BOGAERT?: Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is DR. M-A VAN BOGAERT profitable?: In financial year 2025, DR. M-A VAN BOGAERT made a profit of €57,075.
Where can I find the annual accounts of DR. M-A VAN BOGAERT?: DR. M-A VAN BOGAERT filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. M-A VAN BOGAERT due?: By 31-07-2027, for financial year 2026.Timeline